381 related articles for article (PubMed ID: 17207691)
1. PET/CT in non-small cell lung cancer staging-promises and problems.
Devaraj A; Cook GJ; Hansell DM
Clin Radiol; 2007 Feb; 62(2):97-108. PubMed ID: 17207691
[TBL] [Abstract][Full Text] [Related]
2. Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging.
Shim SS; Lee KS; Kim BT; Chung MJ; Lee EJ; Han J; Choi JY; Kwon OJ; Shim YM; Kim S
Radiology; 2005 Sep; 236(3):1011-9. PubMed ID: 16014441
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness analysis of strategies introducing integrated ¹⁸F-FDG PET/CT into the mediastinal lymph node staging of non-small-cell lung cancer.
Han Y; Xiao H; Zhou Z; Yuan M; Zeng Y; Wu H; Fang Y
Nucl Med Commun; 2015 Mar; 36(3):234-41. PubMed ID: 25460305
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of hybrid PET/CT for staging of non-small cell lung cancer.
Schreyögg J; Weller J; Stargardt T; Herrmann K; Bluemel C; Dechow T; Glatting G; Krause BJ; Mottaghy F; Reske SN; Buck AK
J Nucl Med; 2010 Nov; 51(11):1668-75. PubMed ID: 21051648
[TBL] [Abstract][Full Text] [Related]
5. [PET with (18)F-fluorodeoxyglucose for staging of non-small cell lung cancer].
Weber WA; Dietlein M; Hellwig D; Kirsch CM; Schicha H; Schwaiger M
Nuklearmedizin; 2003 Aug; 42(4):135-44. PubMed ID: 12937692
[TBL] [Abstract][Full Text] [Related]
6. Integrated PET/CT in imaging of non-small cell lung cancer.
Mattar EH
J Egypt Natl Canc Inst; 2007 Dec; 19(4):263-74. PubMed ID: 19652669
[TBL] [Abstract][Full Text] [Related]
7. The use of positron emission tomography (PET) in the staging/evaluation, treatment, and follow-up of patients with lung cancer: a critical review.
Mac Manus M; Hicks RJ
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1298-306. PubMed ID: 19028270
[No Abstract] [Full Text] [Related]
8. The maximum standardized uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodules.
Bryant AS; Cerfolio RJ
Ann Thorac Surg; 2006 Sep; 82(3):1016-20. PubMed ID: 16928527
[TBL] [Abstract][Full Text] [Related]
9. Positron emission tomography staging of pleural deposits following Monaldi's procedure: an accurate reflection or a false staging?
Al-Sarraf N; Doddakula K; Wedde T; Young V
Interact Cardiovasc Thorac Surg; 2007 Apr; 6(2):260-1. PubMed ID: 17669837
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness analysis of strategies introducing FDG-PET into the mediastinal staging of non-small-cell lung cancer from the French healthcare system perspective.
Alzahouri K; Lejeune C; Woronoff-Lemsi MC; Arveux P; Guillemin F
Clin Radiol; 2005 Apr; 60(4):479-92. PubMed ID: 15767106
[TBL] [Abstract][Full Text] [Related]
11. Role of 18F-FDG PET in assessment of response in non-small cell lung cancer.
Hicks RJ
J Nucl Med; 2009 May; 50 Suppl 1():31S-42S. PubMed ID: 19380411
[TBL] [Abstract][Full Text] [Related]
12. Factors causing inaccurate staging of mediastinal nodal involvement in non-small cell lung cancer patients staged by positron emission tomography.
Al-Sarraf N; Aziz R; Doddakula K; Gately K; Wilson L; McGovern E; Young V
Interact Cardiovasc Thorac Surg; 2007 Jun; 6(3):350-3. PubMed ID: 17669863
[TBL] [Abstract][Full Text] [Related]
13. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.
Billé A; Pelosi E; Skanjeti A; Arena V; Errico L; Borasio P; Mancini M; Ardissone F
Eur J Cardiothorac Surg; 2009 Sep; 36(3):440-5. PubMed ID: 19464906
[TBL] [Abstract][Full Text] [Related]
14. Advances in positron emission tomography technology have increased the need for surgical staging in non-small cell lung cancer.
Lee BE; von Haag D; Lown T; Lau D; Calhoun R; Follette D
J Thorac Cardiovasc Surg; 2007 Mar; 133(3):746-52. PubMed ID: 17320577
[TBL] [Abstract][Full Text] [Related]
15. New horizons in staging for non-small-cell lung cancer.
Lardinois D
J Clin Oncol; 2006 Apr; 24(12):1785-7. PubMed ID: 16567767
[No Abstract] [Full Text] [Related]
16. FDG PET: advantages for staging the mediastinum?
Franzius C
Lung Cancer; 2004 Aug; 45 Suppl 2():S69-74. PubMed ID: 15552784
[TBL] [Abstract][Full Text] [Related]
17. Critical review of PET-CT for radiotherapy planning in lung cancer.
Senan S; De Ruysscher D
Crit Rev Oncol Hematol; 2005 Dec; 56(3):345-51. PubMed ID: 15990331
[TBL] [Abstract][Full Text] [Related]
18. Virtual 18F-FDG PET/CT bronchoscopy for lymph node staging in non-small-cell lung cancer patients: present and future applications.
Buchbender C; Herbrik M; Treffert J; Forsting M; Bockisch A; Antoch G; Heusner TA
Expert Rev Med Devices; 2012 May; 9(3):241-7. PubMed ID: 22702254
[TBL] [Abstract][Full Text] [Related]
19. Optimal imaging protocols for lung cancer staging: CT, PET, MR imaging, and the role of imaging.
Paul NS; Ley S; Metser U
Radiol Clin North Am; 2012 Sep; 50(5):935-49. PubMed ID: 22974779
[TBL] [Abstract][Full Text] [Related]
20. 18FDG-PET-CT in the follow-up of non-small cell lung cancer patients after radical radiotherapy with or without chemotherapy: an economic evaluation.
van Loon J; Grutters JP; Wanders R; Boersma L; Dingemans AM; Bootsma G; Geraedts W; Pitz C; Simons J; Brans B; Snoep G; Hochstenbag M; Lambin P; De Ruysscher D
Eur J Cancer; 2010 Jan; 46(1):110-9. PubMed ID: 19944595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
